Edge Medical Robotics is a leading brand in the field of minimally invasive surgical solutions. Established in May 2017 by Dr. Jianchen Wang and Dr.

Yuanqian Gao, graduates of renowned US institutions like MIT and Harvard, Edge Medical Robotics is committed to designing, developing, and manufacturing surgical robots. They specialize in robotic systems and instruments for minimally invasive surgeries, offering innovative solutions for surgical procedures. With a strong focus on research and development, Edge Medical Robotics has independently mastered core technologies related to surgical robotics.

They hold over 500 patents and have successfully completed crucial clinical trials for both multi-port and single-port laparoscopic robotic surgeries, making them the first company in China to achieve this milestone. Backed by prominent investors such as Sequoia Capital, Temasek Holdings, OrbiMed, and more, Edge Medical Robotics has gained significant recognition as a trusted provider of surgical innovation. Their flagship product, the Edge® MP1000, has become the first domestically produced laparoscopic surgical robot to be widely adopted in various departments across China.

With a team comprising scientists and engineers from prestigious institutions worldwide, Edge Medical Robotics combines expertise in mechanical engineering, medicine, medical engineering, computer graphics, computer science, electronics, materials science, and artificial intelligence. Their dedication to excellence has positioned them as a leading force in the field of surgical robotics. Edge Medical Robotics takes pride in their achievements and is honored to receive several accolades, including being named one of the Top 50 Most Innovative Technology Companies in the Guangdong-Hong Kong-Macao Greater Bay Area.

They strive to empower surgeons, benefit patients, and continue pushing the boundaries of surgical robotics to make it a standard tool in operating rooms worldwide